1. Home
  2. MDWD vs VRA Comparison

MDWD vs VRA Comparison

Compare MDWD & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$18.68

Market Cap

238.5M

Sector

Health Care

ML Signal

HOLD

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$2.32

Market Cap

60.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDWD
VRA
Founded
2000
1982
Country
Israel
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
238.5M
60.6M
IPO Year
2014
2010

Fundamental Metrics

Financial Performance
Metric
MDWD
VRA
Price
$18.68
$2.32
Analyst Decision
Strong Buy
Buy
Analyst Count
2
3
Target Price
$37.50
$4.00
AVG Volume (30 Days)
87.0K
1.2M
Earning Date
11-20-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,932,000.00
$324,296,000.00
Revenue This Year
$15.89
N/A
Revenue Next Year
$25.33
$2.33
P/E Ratio
N/A
N/A
Revenue Growth
6.15
N/A
52 Week Low
$14.14
$1.39
52 Week High
$22.51
$4.09

Technical Indicators

Market Signals
Indicator
MDWD
VRA
Relative Strength Index (RSI) 56.18 50.28
Support Level $18.55 $2.25
Resistance Level $19.30 $2.50
Average True Range (ATR) 0.57 0.20
MACD 0.02 0.02
Stochastic Oscillator 62.87 81.58

Price Performance

Historical Comparison
MDWD
VRA

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.

Share on Social Networks: